Literature DB >> 19901273

Active HIF-1 in the normal human retina.

John M Hughes1, Arjan J Groot, Petra van der Groep, René Sersansie, Marc Vooijs, Paul J van Diest, Cornelis J F Van Noorden, Reinier O Schlingemann, Ingeborg Klaassen.   

Abstract

A unique feature of the retina is the presence of photoreceptors, which require an enormous amount of oxygen for the conversion of light to an electrical signal. Hypoxia-inducible factor-1 alpha (HIF-1alpha) is a transcription factor that is the master regulator of cellular adaptation to low oxygen tension. Only in hypoxic conditions is HIF-1alpha protein stabilized and translocated to the nucleus, where it induces transcription of target genes involved in oxygen delivery and energy metabolism. We hypothesized that HIF-1alpha is constitutively stabilized and active in the normal human retina. We investigated the cellular distribution of HIF-1alpha and the expression of its downstream targets, vascular endothelial growth factor (VEGF), glucose transporter 1 (GLUT-1), and carbonic anhydrase IX (CAIX), by immunohistochemistry and immunoblotting in the retina of normal rats and human donor eyes. Both human and rat retinas displayed prominent staining of HIF-1alpha in nuclei of most cell types in inner and outer nuclear layers and the ganglion cell layer, a cellular distribution pattern which was confirmed in human retina by immunoblotting of nuclear extracts. A negative correlation was found between HIF-1alpha protein levels and postmortem times. In human retina, staining of VEGF, GLUT-1, and CAIX was found. Our observations indicate that active HIF-1 signaling occurs constitutively in the normal human and rat retina, suggesting that HIF-1 has a physiological role in the retina.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19901273      PMCID: PMC2825490          DOI: 10.1369/jhc.2009.953786

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  41 in total

1.  Impaired dark adaptation in polycythemia. Improvement after treatment.

Authors:  U Havelius; S Berglund; P Falke; B Hindfelt; T Krakau
Journal:  Acta Ophthalmol Scand       Date:  2000-02

2.  Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1alpha and VEGF.

Authors:  Vassiliki Poulaki; Wenying Qin; Antonia M Joussen; Peter Hurlbut; Stanley J Wiegand; John Rudge; George D Yancopoulos; Anthony P Adamis
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

3.  Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma.

Authors:  Reinhard Bos; Petra van der Groep; Astrid E Greijer; Avi Shvarts; Sybren Meijer; Herbert M Pinedo; Gregg L Semenza; Paul J van Diest; Elsken van der Wall
Journal:  Cancer       Date:  2003-03-15       Impact factor: 6.860

4.  An anti-angiogenic state in mice and humans with retinal photoreceptor cell degeneration.

Authors:  J Lahdenranta; R Pasqualini; R O Schlingemann; M Hagedorn; W B Stallcup; C D Bucana; R L Sidman; W Arap
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-28       Impact factor: 11.205

5.  Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis.

Authors:  R Bos; H Zhong; C F Hanrahan; E C Mommers; G L Semenza; H M Pinedo; M D Abeloff; J W Simons; P J van Diest; E van der Wall
Journal:  J Natl Cancer Inst       Date:  2001-02-21       Impact factor: 13.506

Review 6.  Vascular endothelial growth factors and angiogenesis in eye disease.

Authors:  A N Witmer; G F J M Vrensen; C J F Van Noorden; R O Schlingemann
Journal:  Prog Retin Eye Res       Date:  2003-01       Impact factor: 21.198

7.  Increased expression of catalase and superoxide dismutase 2 reduces cone cell death in retinitis pigmentosa.

Authors:  Shinichi Usui; Keiichi Komeima; Sun Young Lee; Young-Joon Jo; Shinji Ueno; Brian S Rogers; Zhihao Wu; Jikui Shen; Lili Lu; Brian C Oveson; Peter S Rabinovitch; Peter A Campochiaro
Journal:  Mol Ther       Date:  2009-03-17       Impact factor: 11.454

Review 8.  Retinal oxygen: fundamental and clinical aspects.

Authors:  Norbert D Wangsa-Wirawan; Robert A Linsenmeier
Journal:  Arch Ophthalmol       Date:  2003-04

Review 9.  Targeting HIF-1 for cancer therapy.

Authors:  Gregg L Semenza
Journal:  Nat Rev Cancer       Date:  2003-10       Impact factor: 60.716

Review 10.  Hypoxia and oxidative stress. Tumour hypoxia--therapeutic considerations.

Authors:  K J Williams; R L Cowen; I J Stratford
Journal:  Breast Cancer Res       Date:  2001-08-07       Impact factor: 6.466

View more
  20 in total

1.  Osteopontin is up-regulated and associated with neutrophil and macrophage infiltration in glioblastoma.

Authors:  Nadia A Atai; Manju Bansal; Cheungh Lo; Joost Bosman; Wikky Tigchelaar; Klazien S Bosch; Ard Jonker; Philip C De Witt Hamer; Dirk Troost; Christopher A McCulloch; Vincent Everts; Cornelis J F Van Noorden; Jaro Sodek
Journal:  Immunology       Date:  2010-08-17       Impact factor: 7.397

2.  Attenuation of diabetic retinopathy in rats by ellagic acid through inhibition of AGE formation.

Authors:  G Raghu; C Akileshwari; V Sudhakar Reddy; G Bhanuprakash Reddy
Journal:  J Food Sci Technol       Date:  2017-05-29       Impact factor: 2.701

3.  Differential activity of NADPH-producing dehydrogenases renders rodents unsuitable models to study IDH1R132 mutation effects in human glioblastoma.

Authors:  Nadia A Atai; Nynke A Renkema-Mills; Joost Bosman; Nadja Schmidt; Denise Rijkeboer; Wikky Tigchelaar; Klazien S Bosch; Dirk Troost; Ard Jonker; Fonnet E Bleeker; Hrvoje Miletic; Rolf Bjerkvig; Philip C De Witt Hamer; Cornelis J F Van Noorden
Journal:  J Histochem Cytochem       Date:  2011-02-10       Impact factor: 2.479

Review 4.  Potential of Telomerase in Age-Related Macular Degeneration-Involvement of Senescence, DNA Damage Response and Autophagy and a Key Role of PGC-1α.

Authors:  Janusz Blasiak; Joanna Szczepanska; Michal Fila; Elzbieta Pawlowska; Kai Kaarniranta
Journal:  Int J Mol Sci       Date:  2021-07-03       Impact factor: 5.923

5.  Human monocytes and macrophages differ in their mechanisms of adaptation to hypoxia.

Authors:  Monique Fangradt; Martin Hahne; Timo Gaber; Cindy Strehl; Roman Rauch; Paula Hoff; Max Löhning; Gerd-Rüdiger Burmester; Frank Buttgereit
Journal:  Arthritis Res Ther       Date:  2012-08-07       Impact factor: 5.156

6.  Analysis of candidate genes for macular telangiectasia type 2.

Authors:  Nancy L Parmalee; Carl Schubert; Joanna E Merriam; Kaija Allikmets; Alan C Bird; Mark C Gillies; Tunde Peto; Maria Figueroa; Martin Friedlander; Marcus Fruttiger; John Greenwood; Stephen E Moss; Lois E H Smith; Carmel Toomes; Chris F Inglehearn; Rando Allikmets
Journal:  Mol Vis       Date:  2010-12-14       Impact factor: 2.711

7.  Co-culture of Retinal and Endothelial Cells Results in the Modulation of Genes Critical to Retinal Neovascularization.

Authors:  Ravindra Kumar; Sandra Harris-Hooker; Ritesh Kumar; Gary Sanford
Journal:  Vasc Cell       Date:  2011-11-23

8.  Increased hypoxia-inducible factor 1alpha expression in rat brain tissues in response to aging.

Authors:  Huqing Wang; Haiqin Wu; Hena Guo; Guilian Zhang; Ru Zhang; Shuqin Zhan
Journal:  Neural Regen Res       Date:  2012-04-05       Impact factor: 5.135

9.  Role of hypoxia-inducible factor-1α and CD146 in epidermal growth factor receptor-mediated angiogenesis in salivary gland adenoid cystic carcinoma.

Authors:  Wei-Ming Wang; Zhi-Li Zhao; Wen-Feng Zhang; Yi-Fang Zhao; Lu Zhang; Zhi-Jun Sun
Journal:  Mol Med Rep       Date:  2015-05-22       Impact factor: 2.952

10.  Role of hypoxia-inducible factor-1α in preconditioning-induced protection of retinal ganglion cells in glaucoma.

Authors:  Yanli Zhu; Lihong Zhang; Jeffrey M Gidday
Journal:  Mol Vis       Date:  2013-11-23       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.